Istvan Petak, Founder and Chief Scientific Officer at Genomate Health, shared on LinkedIn:
“Hello, wonderful Berlin! Hello, ESMO – European Society for Medical Oncology 2025!
I am excited to meet friends and make new ones, hear about the latest breakthroughs in oncology, and start new partnerships in precision oncology. I am here with a fantastic team – Barbara Vodicska, Julia Deri, Robert Doczi, PhD, and Zsuzsanna Farkas. Reach out if you’re interested in our breakthrough algorithmic computational reasoning solution for personalized treatment planning at Genomate Health.
If you are an oncologist, we can help you solve difficult clinical cases with complex molecular profiles, find more treatment options for your patients, and avoid ineffective treatments by uncovering resistance mechanisms with a computational tool that models the complexity of cancer genomics.
If you work in drug discovery, we can assist you in identifying the optimal target population with the highest likelihood of benefit.
If you provide novel molecular diagnostic tests, our Oncompass Medicine team would love to meet you.
See you all in Berlin! Cheers to a bright future in oncology!”
More posts featuring Istvan Petak on OncoDaily.